Therapeutic hypothermia company Life Core Technologies has received its first patents for a medical device that’s designed to cool the brain of patients who’ve suffered from heart attack, stroke and traumatic brain injury.
The three patents apply to the company’s first product, the Excel Cerebral Cooling System, which resembles a neck-immobilization collar and works via a proprietary chemical that can reach temperatures as low as 25 degrees Fahrenheit 20 seconds after activation.
“Being awarded the three patents for our product is a major milestone for Life Core Technologies,” said CEO Mike Burke. “These patents help protect our product, creating great value for Life Core and its customers. The carotid triangle is key to inducing rapid cerebral hypothermia and these patents provide significant rights related to cooling through this area.”
The idea behind the company’s technology is that cooling the brain helps reduce the chances of injury to tissue once blood flow is restored to patients who’ve suffered from heart attack, stroke or traumatic brain injury.
Burke, who was hired earlier this summer at Life Core, said in June that the company is hoping to close a $3 million series A round of investment. The company would use the funding to step up its marketing and add sales managers to work with outside companies that distribute Life Core’s device.
Life Core is selling the device through deals with nine U.S. and Canadian distributors.
